ES2163521T3 - Preparacion de comprimidos de acido fusidico. - Google Patents

Preparacion de comprimidos de acido fusidico.

Info

Publication number
ES2163521T3
ES2163521T3 ES95927705T ES95927705T ES2163521T3 ES 2163521 T3 ES2163521 T3 ES 2163521T3 ES 95927705 T ES95927705 T ES 95927705T ES 95927705 T ES95927705 T ES 95927705T ES 2163521 T3 ES2163521 T3 ES 2163521T3
Authority
ES
Spain
Prior art keywords
preparation
fusidic acid
acid tablets
tablets
tabletting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95927705T
Other languages
English (en)
Inventor
Erik Preben Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Application granted granted Critical
Publication of ES2163521T3 publication Critical patent/ES2163521T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LA PREPARACION DE TABLETAS DE SAL DE SODIO DE ACIDO FUSIDICO SIN COBERTURA ENTERICA EN LA QUE EL INGREDIENTE ACTIVO SE HAYA EN FORMA DE POLVO SECO COMPRIMIDO EN UN COMPRESOR DE ROLLO, A LO QUE SIGUE LA REDUCCION DE TAMAÑO PARA FORMAR UN GRANULADO PARA HACER LAS TABLETAS.
ES95927705T 1994-07-26 1995-07-21 Preparacion de comprimidos de acido fusidico. Expired - Lifetime ES2163521T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9415048A GB9415048D0 (en) 1994-07-26 1994-07-26 Tablet

Publications (1)

Publication Number Publication Date
ES2163521T3 true ES2163521T3 (es) 2002-02-01

Family

ID=10758888

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95927705T Expired - Lifetime ES2163521T3 (es) 1994-07-26 1995-07-21 Preparacion de comprimidos de acido fusidico.

Country Status (20)

Country Link
EP (1) EP0773783B1 (es)
JP (1) JP3853358B2 (es)
KR (1) KR100358614B1 (es)
CN (1) CN1070703C (es)
AT (1) ATE209496T1 (es)
AU (1) AU681980B2 (es)
CA (1) CA2193235C (es)
CZ (1) CZ286197B6 (es)
DE (1) DE69524226T2 (es)
DK (1) DK0773783T3 (es)
ES (1) ES2163521T3 (es)
FI (1) FI117666B (es)
GB (1) GB9415048D0 (es)
HU (1) HU221483B (es)
NZ (1) NZ290806A (es)
PL (1) PL180935B1 (es)
PT (1) PT773783E (es)
RO (1) RO118633B1 (es)
RU (1) RU2140272C1 (es)
WO (1) WO1996003128A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9022098A (en) * 1997-08-20 1999-03-08 Fuisz Technologies Ltd. Process for improving flow and compression of tableting compositions
AU2006310873B2 (en) 2005-10-31 2012-05-24 Leo Pharma A/S Preparation of an antibiotic crystalline fusidic acid
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
JP5249568B2 (ja) * 2007-12-06 2013-07-31 旭化成ケミカルズ株式会社 成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法
DE102008051783A1 (de) * 2008-10-17 2010-04-22 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Valsartan enthaltende Tablette
EP2382968A1 (en) 2010-03-26 2011-11-02 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Particle size distribution of fusidic acid granules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7411402A (nl) * 1973-09-13 1975-03-17 Leo Pharm Prod Ltd Werkwijze voor het bereiden van een middel tegen arthritis.
EP0300073A1 (en) * 1987-07-22 1989-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Use of fusidic acid in the treatment of aids-related complex and full-blown aids

Also Published As

Publication number Publication date
CN1154066A (zh) 1997-07-09
NZ290806A (en) 1998-01-26
AU681980B2 (en) 1997-09-11
PL318261A1 (en) 1997-05-26
PL180935B1 (pl) 2001-05-31
HU221483B (en) 2002-10-28
CA2193235A1 (en) 1996-02-08
CN1070703C (zh) 2001-09-12
CZ22997A3 (en) 1997-04-16
KR100358614B1 (ko) 2003-01-10
HUT76836A (en) 1997-11-28
AU3164495A (en) 1996-02-22
RO118633B1 (ro) 2003-08-29
GB9415048D0 (en) 1994-09-14
FI965214A (fi) 1996-12-27
EP0773783B1 (en) 2001-11-28
HU9700217D0 (en) 1997-04-28
DE69524226T2 (de) 2002-06-27
FI965214A0 (fi) 1996-12-27
CZ286197B6 (cs) 2000-02-16
KR970704447A (ko) 1997-09-06
JPH10502937A (ja) 1998-03-17
ATE209496T1 (de) 2001-12-15
DK0773783T3 (da) 2002-04-02
WO1996003128A1 (en) 1996-02-08
EP0773783A1 (en) 1997-05-21
FI117666B (fi) 2007-01-15
RU2140272C1 (ru) 1999-10-27
JP3853358B2 (ja) 2006-12-06
CA2193235C (en) 2008-03-18
PT773783E (pt) 2002-04-29
DE69524226D1 (de) 2002-01-10

Similar Documents

Publication Publication Date Title
HK1031325A1 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
FI935380A0 (fi) Laekemedel innehaollande S(+)-ibuprofen
ITMI941262A0 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
ES2163521T3 (es) Preparacion de comprimidos de acido fusidico.
NZ313576A (en) Stable solid formulation of enalapril salt and process for preparation thereof
GB2295966B (en) Direct compression tablets
DK0836472T3 (da) Terapeutiske brusesammensætninger
ECSP961662A (es) Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 773783

Country of ref document: ES